ENDOMETRIOID ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIOID ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test drug combo to shrink tumors before surgery
Disease control Recruiting nowThis study is testing whether giving a combination of chemotherapy and an immunotherapy drug (camrelizumab) before surgery can help shrink tumors in people with advanced endometrial cancer. The goal is to see if this approach makes surgery more successful and helps patients live …
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, nab-sirolimus (given by IV) and letrozole (a daily pill), can help control advanced or recurrent endometrial cancer. It is for patients whose cancer has returned or spread and who have had zero to one prior rounds of chemotherapy…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis early-stage study is testing the safety of combining two drugs, atezolizumab and ONC201, for women with advanced or returning endometrial cancer that has spread. The trial will enroll 58 participants, including both obese and non-obese patients, to find the best dose for fut…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC